BERGER FRANKLIN M

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$5.76M
Insider Sells Quantity
8
Insider Sells Sum
$1.97M

Insider Activity of BERGER FRANKLIN M

According to the SEC Form 4 filings, BERGER FRANKLIN M, being in a position of

  1. director at Atea Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 359606 shares for $1.02M,
    over all time since 2020-11-03, has bought 41666 shares for $999,984, and sold 401272 shares for $1.24M.

The largest purchase of all time was on 2021-02-22 and amounted to 57000 shares of ESSA Pharma Inc. for $1.54M.

The largest sale of all time was on 2024-12-10 and amounted to 359606 shares of Atea Pharmaceuticals, Inc. for $1.02M.

Biography of BERGER FRANKLIN M

No biography is available at this moment.

2024-12-10SaleAtea Pharmaceuticals, Inc.
AVIR
director
359,606
0.42%
$2.85$1.02M+5.44%
2023-11-21PurchaseESSA Pharma Inc.
EPIX
director
23,259
0.0523%
$5.73$133,274+7.4%
2023-11-03PurchaseESSA Pharma Inc.
EPIX
director
16,471
0.0373%
$5.99$98,661+3.83%
2023-11-02PurchaseESSA Pharma Inc.
EPIX
director
60,000
0.1371%
$5.35$321,000+16.45%
2022-12-21SaleESSA Pharma Inc.
EPIX
director
72,223
0.1656%
$2.41$174,401+23.01%
2022-12-20SaleESSA Pharma Inc.
EPIX
director
43,617
0.0986%
$2.53$110,351+15.75%
2022-12-16SaleESSA Pharma Inc.
EPIX
director
50,000
0.1156%
$2.67$133,500+12.21%
2022-12-15SaleESSA Pharma Inc.
EPIX
director
82,000
0.1884%
$2.88$235,800+3.52%
2022-12-14SaleESSA Pharma Inc.
EPIX
director
25,000
0.0569%
$3.00$75,000-1.67%
2022-11-14SaleAtea Pharmaceuticals, Inc.
AVIR
director
16,166
0.0289%
$5.16$83,352-31.57%
2022-11-11SaleAtea Pharmaceuticals, Inc.
AVIR
director
25,500
0.0455%
$5.15$131,333-32.4%
2022-03-18PurchaseKezar Life Sciences, Inc.
KZR
20,000
0.0313%
$14.77$295,400-52.05%
2021-02-22PurchaseESSA Pharma Inc.
EPIX
director
57,000
0.1573%
$27.00$1.54M-48.45%
2020-11-03PurchaseAtea Pharmaceuticals, Inc.
AVIR
director
41,666
0.3462%
$24.00$999,984+10.66%
2020-06-11PurchaseKezar Life Sciences, Inc.
KZR
director
100,000
0.2647%
$5.50$550,000+13.64%
2020-02-04PurchaseKezar Life Sciences, Inc.
KZR
director
120,846
0.3145%
$2.60$314,200+69.08%
2018-06-25PurchaseKezar Life Sciences, Inc.
KZR
director
100,000
4.279%
$15.00$1.5M+15.16%
2013-08-20PurchaseEterna Therapeutics Inc.
ERNA
director
500
0.0085%
$3.71$1,855+50%
2013-08-20PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
1,000
0.0018%
$3.71$3,709-5.78%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.